Tumorigenesis and Neoplastic Progression MicroRNA-Mediated Down-Regulation of PRDM 1 / Blimp-1 in Hodgkin / Reed-Sternberg Cells : A Potential Pathogenetic Lesion in Hodgkin Lymphomas

PRDM1/Blimp-1, a master regulator in terminal B-cell differentiation, has been recently identified as a tumor suppressor target for mutational inactivation in diffuse large B-cell lymphomas of the activated B-cell type. Our studies here demonstrate that PRDM1/blimp-1 is also a target for microRNA (miRNA)-mediated down-regulation by miR-9 and let-7a in Hodgkin/Reed-Sternberg (HRS) cells of Hodgkin lymphoma (HL). MiRNA expression profiling by direct miRNA cloning demonstrated that both of these miRNAs are among the most highly expressed in cultured HRS cells. These miRNAs functionally targeted specific binding sites in the 3' untranslated region of PRDM1/blimp-1 mRNA and repressed luciferase reporter activities through repression of translation. In addition, high levels of miR-9 and let-7a in HL cell lines correlated with low levels of PRDM1/Blimp-1. Similar to their in vitro counterparts, the majority of HRS cells in primary HL cases showed weak or no PRDM1/Blimp-1 expression. Over-expression of miR-9 or let-7a reduced PRDM1/Blimp-1 levels in U266 cells by 30% to 50%, whereas simultaneous inhibition of their activities in L428 cells resulted in an approximately 2.6-fold induction in PRDM1/Blimp-1. MiRNA-mediated down-regulation of PRDM1/Blimp-1 may contribute to the phenotype maintenance and pathogenesis of HRS cells by interfering with normal B-cell terminal differentiation, thus representing a novel molecular lesion, as well as a potential therapeutic target in HL.

[1]  M. Saitou.  Germ cell specification in mice. , 2009, Current opinion in genetics & development.

[2]  T. Enver,et al.  MicroRNA expression in lymphocyte development and malignancy , 2008, Leukemia.

[3]  Andrea J. O'Hara,et al.  Gene alteration and precursor and mature microRNA transcription changes contribute to the miRNA signature of primary effusion lymphoma. , 2008, Blood.

[4]  Anton J. Enright,et al.  microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. , 2007, Immunity.

[5]  K. Calame.  MicroRNA-155 function in B Cells. , 2007, Immunity.

[6]  Elizabeth J. Robertson,et al.  Blimp1 regulates development of the posterior forelimb, caudal pharyngeal arches, heart and sensory vibrissae in mice , 2007, Development.

[7]  K. Calame,et al.  Epidermal terminal differentiation depends on B lymphocyte-induced maturation protein-1 , 2007, Proceedings of the National Academy of Sciences.

[8]  M. Shipp,et al.  BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms. , 2007, Blood.

[9]  Wayne Tam,et al.  MicroRNAs in tumorigenesis: a primer. , 2007, The American journal of pathology.

[10]  L. Lim,et al.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.

[11]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[12]  Jhagvaral Hasbold,et al.  Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1. , 2007, Immunity.

[13]  N. Rajewsky,et al.  Regulation of the Germinal Center Response by MicroRNA-155 , 2007, Science.

[14]  Anton J. Enright,et al.  Requirement of bic/microRNA-155 for Normal Immune Function , 2007, Science.

[15]  S. Nutt,et al.  Terminal differentiation of lymphocytes depends on Blimp-1. , 2007, Current opinion in immunology.

[16]  H. Sültmann,et al.  The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. , 2007, Cancer research.

[17]  K. Takatsu,et al.  Interleukin‐5 regulates genes involved in B‐cell terminal maturation , 2006, Immunology.

[18]  Tara L. Naylor,et al.  microRNAs exhibit high frequency genomic alterations in human cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Qiong Shen,et al.  Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination , 2006, Nature Immunology.

[20]  W. Chan,et al.  Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. , 2006, Blood.

[21]  S. Freier,et al.  Improved targeting of miRNA with antisense oligonucleotides , 2006, Nucleic acids research.

[22]  Stefano Monti,et al.  Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma , 2006, The Journal of experimental medicine.

[23]  W. Tam,et al.  miR‐155/BIC as an oncogenic microRNA , 2006, Genes, chromosomes & cancer.

[24]  P. Lipsky,et al.  IL-21 Induces Differentiation of Human Naive and Memory B Cells into Antibody-Secreting Plasma Cells1 , 2005, The Journal of Immunology.

[25]  Chang-Zheng Chen,et al.  MicroRNAs as oncogenes and tumor suppressors. , 2005, The New England journal of medicine.

[26]  A. van den Berg,et al.  BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas , 2005, The Journal of pathology.

[27]  H. Jäck,et al.  Evidence of abortive plasma cell differentiation in Hodgkin and Reed‐Sternberg cells of classical Hodgkin lymphoma , 2005, Hematological oncology.

[28]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[29]  Masaaki Ebara,et al.  A Role for c-fos/Activator Protein 1 in B Lymphocyte Terminal Differentiation1 , 2005, The Journal of Immunology.

[30]  Giorgio Cattoretti,et al.  PRDM1/Blimp‐1 is expressed in human B‐lymphocytes committed to the plasma cell lineage , 2005, The Journal of pathology.

[31]  C. Tunyaplin,et al.  Regulatory events in early and late B-cell differentiation. , 2005, Molecular immunology.

[32]  Wayne Tam,et al.  Accumulation of miR-155 and BIC RNA in human B cell lymphomas. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Küppers,et al.  The Hodgkin and Reed/Sternberg cell. , 2005, The international journal of biochemistry & cell biology.

[34]  Lena Smirnova,et al.  Regulation of miRNA expression during neural cell specification , 2005, The European journal of neuroscience.

[35]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[36]  Jhagvaral Hasbold,et al.  Plasma Cell Ontogeny Defined by Quantitative Changes in Blimp-1 Expression , 2004, The Journal of experimental medicine.

[37]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[38]  Anton J. Enright,et al.  Identification of Virus-Encoded MicroRNAs , 2004, Science.

[39]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[40]  Konstantin Khrapko,et al.  A microRNA array reveals extensive regulation of microRNAs during brain development. , 2003, RNA.

[41]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[42]  I. Lossos,et al.  Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies , 2003, Leukemia.

[43]  K. Wright,et al.  Identification of a Functionally Impaired Positive Regulatory Domain I Binding Factor 1 Transcription Repressor in Myeloma Cell Lines1 , 2003, The Journal of Immunology.

[44]  Andrea Califano,et al.  Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. , 2003, The Journal of clinical investigation.

[45]  H. Stein,et al.  Aberrantly expressed c‐Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF‐κB , 2002, The EMBO journal.

[46]  Liming Yang,et al.  Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. , 2002, Immunity.

[47]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[48]  G. Gaidano,et al.  Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease , 2002, British journal of haematology.

[49]  A. van den Berg,et al.  Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[50]  G. Cattoretti,et al.  Commitment of B Lymphocytes to a Plasma Cell Fate Is Associated with Blimp-1 Expression In Vivo1 , 2000, The Journal of Immunology.

[51]  L. Staudt.  The Molecular and Cellular Origins of Hodgkin's Disease , 2000, The Journal of experimental medicine.

[52]  S. Franceschi,et al.  Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease. , 1998, Blood.

[53]  Juan F. García,et al.  Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies. , 2003, Haematologica.